Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kaixin Holdings (KXIN) Cash & Equivalents (2017 - 2025)

Kaixin Holdings has reported Cash & Equivalents over the past 9 years, most recently at $859000.0 for Q4 2025.

  • Quarterly Cash & Equivalents fell 64.03% to $859000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $859000.0 through Dec 2025, down 64.03% year-over-year, with the annual reading at $859000.0 for FY2025, 64.03% down from the prior year.
  • Cash & Equivalents was $859000.0 for Q4 2025 at Kaixin Holdings, up from $552000.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $7.1 million in Q4 2022 and troughed at $552000.0 in Q2 2025.
  • The 5-year median for Cash & Equivalents is $2.2 million (2023), against an average of $3.3 million.
  • Year-over-year, Cash & Equivalents skyrocketed 767.05% in 2021 and then crashed 73.53% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $5.3 million in 2021, then skyrocketed by 34.94% to $7.1 million in 2022, then plummeted by 70.64% to $2.1 million in 2023, then increased by 14.53% to $2.4 million in 2024, then crashed by 64.03% to $859000.0 in 2025.
  • Per Business Quant, the three most recent readings for KXIN's Cash & Equivalents are $859000.0 (Q4 2025), $552000.0 (Q2 2025), and $2.4 million (Q4 2024).